Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in neoadjuvant luminal breast cancer
NCT01565499Phase 2Completed
- Sponsor
- GEICAM
- Start
- Apr 2012
- Primary completion
- Jun 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by GEICAM. Started Apr 2012; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01565499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565499.